Hemogenyx Pharmaceuticals (UK) Alpha and Beta Analysis

HEMO Stock   343.40  20.90  6.48%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Hemogenyx Pharmaceuticals PLC. It also helps investors analyze the systematic and unsystematic risks associated with investing in Hemogenyx Pharmaceuticals over a specified time horizon. Remember, high Hemogenyx Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Hemogenyx Pharmaceuticals' market risk premium analysis include:
Beta
(1.19)
Alpha
(0.48)
Risk
8.04
Sharpe Ratio
(0.06)
Expected Return
(0.51)
Please note that although Hemogenyx Pharmaceuticals alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Hemogenyx Pharmaceuticals did 0.48  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Hemogenyx Pharmaceuticals PLC stock's relative risk over its benchmark. Hemogenyx Pharmaceuticals has a beta of 1.19  . As returns on the market increase, returns on owning Hemogenyx Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Hemogenyx Pharmaceuticals is expected to outperform it. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Hemogenyx Pharmaceuticals Backtesting, Hemogenyx Pharmaceuticals Valuation, Hemogenyx Pharmaceuticals Correlation, Hemogenyx Pharmaceuticals Hype Analysis, Hemogenyx Pharmaceuticals Volatility, Hemogenyx Pharmaceuticals History and analyze Hemogenyx Pharmaceuticals Performance.

Hemogenyx Pharmaceuticals Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Hemogenyx Pharmaceuticals market risk premium is the additional return an investor will receive from holding Hemogenyx Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Hemogenyx Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Hemogenyx Pharmaceuticals' performance over market.
α-0.48   β-1.19

Hemogenyx Pharmaceuticals expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Hemogenyx Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Hemogenyx Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Hemogenyx Pharmaceuticals Market Price Analysis

Market price analysis indicators help investors to evaluate how Hemogenyx Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hemogenyx Pharmaceuticals shares will generate the highest return on investment. By understating and applying Hemogenyx Pharmaceuticals stock market price indicators, traders can identify Hemogenyx Pharmaceuticals position entry and exit signals to maximize returns.

Hemogenyx Pharmaceuticals Return and Market Media

The median price of Hemogenyx Pharmaceuticals for the period between Mon, Sep 23, 2024 and Sun, Dec 22, 2024 is 517.2 with a coefficient of variation of 17.15. The daily time series for the period is distributed with a sample standard deviation of 86.37, arithmetic mean of 503.48, and mean deviation of 70.62. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting - Yahoo Finance
11/22/2024
2
Hemogenyx Pharmaceuticals shareholders approve share restructure - Investing.com
12/09/2024
3
Hemogenyx Pharmaceuticals Sets New 12-Month Low - Heres What Happened - MarketBeat
12/17/2024

About Hemogenyx Pharmaceuticals Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Hemogenyx or other stocks. Alpha measures the amount that position in Hemogenyx Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hemogenyx Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hemogenyx Pharmaceuticals' short interest history, or implied volatility extrapolated from Hemogenyx Pharmaceuticals options trading.

Build Portfolio with Hemogenyx Pharmaceuticals

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Hemogenyx Stock Analysis

When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.